Abeona Therapeutics ABEO
NASDAQ ABEO
$4.40 -0.07 (-1.57%)
At close: Oct 23, 2026 · 4:00 PM EDT

Abeona Therapeutics (ABEO) Construction in Progress (2017 - 2018)

Updated

Abeona Therapeutics (ABEO) reported Construction in Progress of $409,000 for Q4 2018, down 10.1% from $455,000 a year earlier.

Analysis

Abeona Therapeutics (ABEO) Construction in Progress (2017 - 2018) Analysis & Trends

  • By year, Construction in Progress came in at $455,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Abeona Therapeutics 251.30 Mn -462.66 Mn 7.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 409,000.00
Dec 31, 2017 455,000.00
API Access

Abeona Therapeutics Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=ABEO&period=max&api_key=YOUR_API_KEY